Disodium cromoglycate and inhibition of passive cutaneous anaphylaxis.
D001249:Asthma / Q000276:immunology*; D002867:Chromones / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004205:Cromolyn Sodium / Q000627:therapeutic use; D006801:Humans; D010323:Passive Cutaneous Anaphylaxis; D010919:Placebos
D002867:Chromones; D010919:Placebos; D004205:Cromolyn Sodium